SCHITO, GIAN CARLO
 Distribuzione geografica
Continente #
EU - Europa 3.628
Totale 3.628
Nazione #
IT - Italia 3.628
Totale 3.628
Città #
Genova 2.719
Rapallo 512
Genoa 384
Bordighera 13
Totale 3.628
Nome #
Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime. 141
Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms 139
L'azitromicina induce l'eliminazione di diversi plasmodi in Klebsiella pneumoniae- 133
Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa 128
Coumermycin inhibition of murine retrovirus replication in cultured cells. 124
Active surveillance of Streptococcus pneumoniae bacteremia in Italian children 122
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 119
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis 118
Post antibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA 116
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 112
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 108
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy 108
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. 106
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. 106
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance 104
Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). 104
Recent findings from multinational resistance surveys: are we 'PROTEKTed' from resistance? 97
Antibacterial profile of flurithromycin, a new macrolide 96
Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000. 93
Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital 90
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. 89
Whole blood collection on filter paper is an effective means of obtaining samples for Human Immunodeficiency Virus antibody. AIDS RESEARCH AND HUMAN RETROVIRUSES 4:131-136, 1988. 82
Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens. 77
Activity of levofloxacin on contemporary respiratory pathogens 76
In vitro interaction of flurithromycin with other drugs employed in the therapy of respiratory infections. 75
The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy 74
Antimicrobial and ATP synthase modulating activity of the surface constituents of Salvia tingitana Etl. (Lamiaceae) 73
Attività antistafilococcica del cefdinir, una nuova cefalosporina orale, in condizione di supera- e sub-MIC. 72
In vitro activity of ertapenem against selected respiratory pathogens 71
Parallel We-stern blot analysis for HIV-1 and HIV-2 antibodies: Absence of HIV-2 in-fection in Italian subjects at risk for AIDS. 67
Antistaphylococcal activity of cefdinir alone and in combination with other drugs. 64
Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997-1999) 61
Soppressione fenotipica di gyrA (Ts) e di gyrB (Ts) mediante integrazione cromosomica di F'Lac. 60
Influenza di alcuni chemioterapici sulla eliminazione di diversi plasmodi in Escherichia coli. 54
Microbiologia clinica di un nuovo macrolide: la fluritromicina. 49
Sesterterpenes from Salvia tingitana Etl. (Lamiaceae) 47
Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine. 45
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretative reading of antimicrobial resistance tests 44
Efficacy of Ursolic Acid-Enriched Water-Soluble and Not Cytotoxic Nanoparticles against Enterococci 36
Biocidal Cationic Macromolecules Irrespective of Bacterial Resistance: Our Best Achievements (Our Ongoing Studies) 36
Messa a punto di una metodica veloce per la determinazione dei geni di resistenza ai macrolidi in S.pneumoniae. 33
Biocidal Cationic Macromolecules Irrespective of Bacterial Resistance: Our Experience 31
Biocidal Cationic Macromolecules Irrespective of Bacterial Resistance: Our Best Achievements 25
Synthesis and Antibacterial Activity of Cationic Amino Acid-Conjugated Dendrimers Loaded with a Mixture of Two Triterpenoid Acids 21
Hydrogel Formulations of Antibacterial Pyrazoles Applying a Synthetic Polystyrene-Based Cationic Resin as Gelling Material 16
Improved Antibacterial Properties of Pyrazole-Based Water-Soluble Dendrimer Nanoparticles 8
Nanotubes: Carbon-Based Fibers and Bacterial Nano-Conduits Both Arousing a Global Interest and Conflicting Opinions 2
Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review 1
Totale 3.653
Categoria #
all - tutte 9.709
article - articoli 6.999
book - libri 0
conference - conferenze 2.710
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019162 0 0 0 0 0 0 0 0 0 37 71 54
2019/2020959 24 19 59 50 81 93 158 54 80 174 129 38
2020/2021233 15 11 30 11 16 27 17 22 23 17 29 15
2021/2022511 8 48 33 43 30 30 37 130 19 43 24 66
2022/2023628 66 54 20 78 80 93 2 48 101 11 65 10
2023/2024291 20 48 19 46 36 72 19 19 6 6 0 0
Totale 3.653